Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

Name: Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure
Published: 2014
License: Public Domain

Poitiers University Hospital · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

critical-care pharmacokinetics

renal failure, critical care, gram positive bacteria, pharmacokinetics, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

Related documents